Actively Recruiting
Neurosurgical Outcome Network for Predicting Outcomes in Neurosurgery
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-03-30
4500
Participants Needed
27
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating outcomes and their predictors in various neurosurgical conditions to improve the quality and consistency of research and clinical care. The study focuses on standardizing the assessment of clinical, cognitive, and psychological status before and after neurosurgical interventions across multiple centers. This effort aims to create a common language in routine practice and support better therapeutic decisions through shared data and identified predictive factors. The study collects detailed clinical and demographic information from patients undergoing neurosurgery for a wide range of conditions, including tumors, vascular diseases, trauma, spinal disorders, functional pathologies, peripheral nerve issues, and malformations. Data such as comorbidities, anesthesia details, complications, and psychological assessments are gathered before surgery and at follow-ups, with timing varying by condition. An artificial intelligence analysis will be used to identify important predictors and outcomes. Participants will provide data over a period of up to five years, including sociodemographic details, clinical status, cognitive and psychological assessments, and complication records. The study monitors these factors preoperatively and postoperatively to describe outcomes and explore associations with preoperative indicators. The long-term collection of data supports understanding neurosurgical results and guiding patient care more precisely.
CONDITIONS
Brief Title
Neurosurgical Outcome Network
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosis of neuro-oncological tumors excluding skull base tumors
- Presence of basicranial tumors from anterior, middle, or posterior cranial fossae or sellar regions
- Vascular pathologies including aneurysms, arteriovenous malformations, cavernomas, Moyamoya disease, dural fistulas, or nontraumatic hematomas
- Traumatic brain injuries such as diffuse damage, subdural or extradural hematomas, subarachnoid hemorrhage, intraparenchymal hematoma, fractures, or hydrocephalus
- Spinal pathologies including degenerative, myelopathic, traumatic, and oncologic conditions
- Functional disorders like Parkinson's disease, spasticity, trigeminal neuralgia, craniofacial pain, neuropathic pain, tremor, dystonias, obsessive-compulsive disorder, drug-resistant epilepsy, depression, or normotensive hydrocephalus
- Peripheral nervous system conditions including nerve compression syndromes, tumors, and trauma
- Malformative conditions such as Chiari malformation type 1, craniostenoses, and malformative hydrocephalus
- Adequate understanding of Italian language
- Diagnosis of glioma, meningioma, vascular pathology, or spinal pathology to qualify for cognitive and psychological assessment
You will not qualify if you...
- History of psychiatric diseases or current use of psychotropic drugs for cognitive and psychological assessments
- Presence of overt cognitive decline not caused by neurosurgical injury
- Age younger than 18 years
Research Team
P
Paolo Ferroli, MD
M
Morgan A Broggi, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here